Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kythera Biopharmaceuticals Inc (KYTH) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kythera Biopharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1436304.
Total stock buying since 2014: $0.
Total stock sales since 2014: $34,893,884.
Total stock option exercises since 2014: $8,751,802.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2015 | 0 | $0 | 487,980 | $32,692,006 | 371,845 | $8,695,001 |
| 2014 | 0 | $0 | 61,084 | $2,201,878 | 8,250 | $56,801 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2015-09 | 0 | $0 | 317,232 | $23,761,454 | 330,999 | $8,400,329 |
| 2015-08 | 0 | $0 | 2,978 | $222,546 | 0 | $0 |
| 2015-07 | 0 | $0 | 250 | $18,795 | 0 | $0 |
| 2015-06 | 0 | $0 | 52,263 | $3,519,074 | 0 | $0 |
| 2015-05 | 0 | $0 | 16,750 | $769,953 | 0 | $0 |
| 2015-04 | 0 | $0 | 30,449 | $1,442,189 | 0 | $0 |
| 2015-03 | 0 | $0 | 40,822 | $1,943,252 | 5,987 | $112,705 |
| 2015-02 | 0 | $0 | 15,186 | $584,621 | 0 | $0 |
| 2015-01 | 0 | $0 | 12,050 | $430,122 | 34,859 | $181,967 |
| 2014-12 | 0 | $0 | 8,014 | $302,124 | 375 | $3,082 |
| 2014-11 | 0 | $0 | 7,850 | $274,202 | 375 | $3,082 |
| 2014-10 | 0 | $0 | 7,689 | $255,836 | 375 | $3,082 |
| 2014-09 | 0 | $0 | 7,525 | $280,743 | 375 | $3,082 |
| 2014-08 | 0 | $0 | 7,364 | $247,194 | 375 | $3,082 |
| 2014-07 | 0 | $0 | 13,328 | $524,802 | 2,625 | $21,577 |
| 2014-06 | 0 | $0 | 7,039 | $238,365 | 3,375 | $17,602 |
| 2014-05 | 0 | $0 | 2,275 | $78,612 | 375 | $2,212 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-09-25 | Smither John W (Chief Financial Officer) | Option Ex | 14,017 | 4.84 | 67,842 |
| 2015-09-24 | Beddingfield Iii Frederick (Chief Medical Officer) | Sale | 110,638 | 74.91 | 8,287,560 |
| 2015-09-24 | Beddingfield Iii Frederick (Chief Medical Officer) | Option Ex | 110,638 | 33.26 | 3,679,266 |
| 2015-09-24 | Smither John W (Chief Financial Officer) | Sale | 26,917 | 74.90 | 2,016,083 |
| 2015-09-24 | Smither John W (Chief Financial Officer) | Option Ex | 26,917 | 35.76 | 962,551 |
| 2015-09-23 | Sandoval Elisabeth (Chief Commercial Officer) | Sale | 72,532 | 74.90 | 5,432,646 |
| 2015-09-23 | Sandoval Elisabeth (Chief Commercial Officer) | Option Ex | 72,532 | 21.99 | 1,594,978 |
| 2015-09-23 | Smither John W (Chief Financial Officer) | Sale | 26,918 | 74.90 | 2,016,158 |
| 2015-09-23 | Smither John W (Chief Financial Officer) | Option Ex | 26,918 | 17.86 | 480,755 |
| 2015-09-23 | Klein Keith (General Counsel) | Sale | 52,153 | 74.90 | 3,906,259 |
| 2015-09-23 | Klein Keith (General Counsel) | Option Ex | 52,153 | 26.58 | 1,386,226 |
| 2015-09-22 | Sandoval Elisabeth (Chief Commercial Officer) | Sale | 10,590 | 74.90 | 793,191 |
| 2015-09-22 | Sandoval Elisabeth (Chief Commercial Officer) | Option Ex | 10,590 | 8.22 | 87,049 |
| 2015-09-22 | Smither John W (Chief Financial Officer) | Sale | 5,591 | 74.90 | 418,765 |
| 2015-09-22 | Smither John W (Chief Financial Officer) | Option Ex | 5,591 | 8.22 | 45,958 |
| 2015-09-22 | Klein Keith (General Counsel) | Sale | 10,589 | 74.90 | 793,116 |
| 2015-09-22 | Klein Keith (General Counsel) | Option Ex | 10,589 | 8.22 | 87,041 |
| 2015-09-18 | Smither John W (Chief Financial Officer) | Sale | 1,054 | 74.95 | 78,997 |
| 2015-09-18 | Smither John W (Chief Financial Officer) | Option Ex | 1,054 | 8.22 | 8,663 |
| 2015-09-01 | Samuels Camille D | Sale | 250 | 74.72 | 18,679 |
| 2015-08-05 | Sandoval Elisabeth (Chief Commercial Officer) | Sale | 2,728 | 74.75 | 203,918 |
| 2015-08-03 | Samuels Camille D | Sale | 250 | 74.51 | 18,628 |
| 2015-07-01 | Samuels Camille D | Sale | 250 | 75.18 | 18,795 |
| 2015-06-25 | Beddingfield Iii Frederick (Chief Medical Officer) | Sale | 19,543 | 75.74 | 1,480,245 |
| 2015-06-25 | Smither John W (Chief Financial Officer) | Sale | 4,600 | 75.50 | 347,300 |
| 2015-06-24 | Beddingfield Iii Frederick (Chief Medical Officer) | Sale | 11,040 | 75.52 | 833,784 |
| 2015-06-01 | Leonard Keith R (President & CEO) | Sale | 16,830 | 50.22 | 845,253 |
| 2015-06-01 | Samuels Camille D | Sale | 250 | 49.97 | 12,492 |
| 2015-05-20 | Leonard Keith R (President & CEO) | Sale | 3,500 | 50.04 | 175,150 |
| 2015-05-01 | Leonard Keith R (President & CEO) | Sale | 13,000 | 44.90 | 583,661 |
| 2015-05-01 | Samuels Camille D | Sale | 250 | 44.57 | 11,142 |
| 2015-04-30 | Rich Douglas A. (Vice President Operations) | Sale | 995 | 45.55 | 45,322 |
| 2015-04-30 | Sandoval Elisabeth (Chief Commercial Officer) | Sale | 1,654 | 45.55 | 75,339 |
| 2015-04-30 | Beddingfield Iii Frederick (Chief Medical Officer) | Sale | 2,041 | 45.51 | 92,885 |
| 2015-04-30 | Smither John W (Chief Financial Officer) | Sale | 2,041 | 45.49 | 92,845 |
| 2015-04-30 | Klein Keith (General Counsel) | Sale | 1,654 | 45.52 | 75,290 |
| 2015-04-30 | Leonard Keith R (President & CEO) | Sale | 5,557 | 45.44 | 252,510 |
| 2015-04-15 | Leonard Keith R (President & CEO) | Sale | 2,709 | 50.54 | 136,910 |
| 2015-04-01 | Leonard Keith R (President & CEO) | Sale | 13,548 | 48.63 | 658,812 |
| 2015-04-01 | Samuels Camille D | Sale | 250 | 49.10 | 12,276 |
| 2015-03-24 | Nelsen Robert (Other) | Option Ex | 5,987 | 18.82 | 112,705 |
| 2015-03-16 | Leonard Keith R (President & CEO) | Sale | 5,312 | 50.40 | 267,714 |
| 2015-03-09 | David Nathaniel E | Sale | 6,185 | 55.00 | 340,175 |
| 2015-03-05 | Smither John W (Chief Financial Officer) | Sale | 4,200 | 48.33 | 202,986 |
| 2015-03-05 | David Nathaniel E | Sale | 12,375 | 48.49 | 600,125 |
| 2015-03-02 | David Nathaniel E | Sale | 1,875 | 41.47 | 77,763 |
| 2015-03-02 | Leonard Keith R (President & CEO) | Sale | 10,625 | 41.82 | 444,316 |
| 2015-03-02 | Samuels Camille D | Sale | 250 | 40.70 | 10,173 |
| 2015-02-18 | Smither John W (Chief Financial Officer) | Sale | 1,000 | 42.00 | 42,000 |
| 2015-02-17 | Smither John W (Chief Financial Officer) | Sale | 1,000 | 40.00 | 40,000 |
| 2015-02-17 | David Nathaniel E | Sale | 807 | 40.00 | 32,280 |
| 2015-02-17 | Leonard Keith R (President & CEO) | Sale | 4,165 | 40.46 | 168,503 |
| 2015-02-02 | David Nathaniel E | Sale | 1,715 | 36.89 | 63,266 |
| 2015-02-02 | Leonard Keith R (President & CEO) | Sale | 6,249 | 36.69 | 229,244 |
| 2015-02-02 | Samuels Camille D | Sale | 250 | 37.31 | 9,328 |
| 2015-01-29 | Smither John W (Chief Financial Officer) | Sale | 1,000 | 38.00 | 38,000 |
| 2015-01-23 | Smither John W (Chief Financial Officer) | Sale | 3,000 | 35.73 | 107,205 |
| 2015-01-16 | Samuels Camille D | Sale | 250 | 36.62 | 9,155 |
| 2015-01-06 | Leonard Keith R (President & CEO) | Option Ex | 28,643 | 6.06 | 173,576 |
| 2015-01-05 | Smither John W (Chief Financial Officer) | Option Ex | 6,216 | 1.35 | 8,391 |
| 2015-01-02 | David Nathaniel E | Sale | 1,680 | 35.30 | 59,298 |
| 2015-01-02 | Leonard Keith R (President & CEO) | Sale | 6,120 | 35.37 | 216,464 |
| 2014-12-22 | Smither John W (Chief Financial Officer) | Sale | 375 | 35.49 | 13,308 |
| 2014-12-22 | Smither John W (Chief Financial Officer) | Option Ex | 375 | 8.22 | 3,082 |
| 2014-12-01 | David Nathaniel E | Sale | 1,645 | 37.67 | 61,968 |
| 2014-12-01 | Leonard Keith R (President & CEO) | Sale | 5,994 | 37.85 | 226,848 |
| 2014-11-20 | Smither John W (Chief Financial Officer) | Sale | 375 | 34.83 | 13,061 |
| 2014-11-20 | Smither John W (Chief Financial Officer) | Option Ex | 375 | 8.22 | 3,082 |
| 2014-11-03 | David Nathaniel E | Sale | 1,610 | 34.90 | 56,189 |
| 2014-11-03 | Leonard Keith R (President & CEO) | Sale | 5,865 | 34.95 | 204,952 |
| 2014-10-23 | David Nathaniel E | Sale | 225 | 35.00 | 7,875 |
| 2014-10-23 | Leonard Keith R (President & CEO) | Sale | 1,913 | 35.13 | 67,209 |
| 2014-10-20 | Smither John W (Chief Financial Officer) | Sale | 375 | 32.53 | 12,198 |
| 2014-10-20 | Smither John W (Chief Financial Officer) | Option Ex | 375 | 8.22 | 3,082 |
| 2014-10-01 | David Nathaniel E | Sale | 1,350 | 32.60 | 44,014 |
| 2014-10-01 | Leonard Keith R (President & CEO) | Sale | 3,826 | 32.55 | 124,540 |
| 2014-09-22 | Smither John W (Chief Financial Officer) | Sale | 375 | 35.61 | 13,353 |
| 2014-09-22 | Smither John W (Chief Financial Officer) | Option Ex | 375 | 8.22 | 3,082 |
| 2014-09-02 | David Nathaniel E | Sale | 1,540 | 37.37 | 57,548 |
| 2014-09-02 | Leonard Keith R (President & CEO) | Sale | 5,610 | 37.41 | 209,842 |
| 2014-08-20 | Smither John W (Chief Financial Officer) | Sale | 375 | 35.04 | 13,140 |
| 2014-08-20 | Smither John W (Chief Financial Officer) | Option Ex | 375 | 8.22 | 3,082 |
| 2014-08-04 | David Nathaniel E | Sale | 215 | 35.00 | 7,525 |
| 2014-08-04 | Leonard Keith R (President & CEO) | Sale | 1,828 | 35.10 | 64,162 |
| 2014-08-01 | David Nathaniel E | Sale | 1,290 | 32.76 | 42,253 |
| 2014-08-01 | Leonard Keith R (President & CEO) | Sale | 3,656 | 32.85 | 120,114 |
| 2014-07-21 | Smither John W (Chief Financial Officer) | Sale | 375 | 33.40 | 12,525 |
| 2014-07-21 | Smither John W (Chief Financial Officer) | Option Ex | 375 | 8.22 | 3,082 |
| 2014-07-02 | Smither John W (Chief Financial Officer) | Sale | 2,250 | 40.00 | 90,000 |
| 2014-07-02 | Smither John W (Chief Financial Officer) | Option Ex | 2,250 | 8.22 | 18,495 |
| 2014-07-02 | David Nathaniel E | Sale | 308 | 40.00 | 12,320 |
| 2014-07-02 | Leonard Keith R (President & CEO) | Sale | 3,570 | 40.18 | 143,431 |
| 2014-07-01 | David Nathaniel E | Sale | 1,470 | 39.14 | 57,532 |
| 2014-07-01 | Leonard Keith R (President & CEO) | Sale | 5,355 | 39.03 | 208,994 |
| 2014-06-20 | Smither John W (Chief Financial Officer) | Sale | 375 | 38.06 | 14,272 |
| 2014-06-20 | Smither John W (Chief Financial Officer) | Option Ex | 375 | 8.22 | 3,082 |
| 2014-06-16 | Leonard Keith R (President & CEO) | Sale | 1,743 | 36.37 | 63,396 |
| 2014-06-13 | Smither John W (Chief Financial Officer) | Option Ex | 3,000 | 4.84 | 14,520 |
| 2014-06-09 | David Nathaniel E | Sale | 205 | 35.00 | 7,175 |
| 2014-06-02 | David Nathaniel E | Sale | 1,230 | 32.56 | 40,043 |
| 2014-06-02 | Leonard Keith R (President & CEO) | Sale | 3,486 | 32.55 | 113,479 |
| 2014-05-27 | Leonard Keith R (President & CEO) | Sale | 1,700 | 35.02 | 59,537 |
| 2014-05-20 | Smither John W (Chief Financial Officer) | Sale | 375 | 32.20 | 12,075 |
| 2014-05-20 | Smither John W (Chief Financial Officer) | Option Ex | 375 | 5.90 | 2,212 |
| 2014-05-13 | David Nathaniel E | Sale | 200 | 35.00 | 7,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of KYTH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kythera Biopharmaceuticals Inc (symbol KYTH, CIK number 1436304) see the Securities and Exchange Commission (SEC) website.